Other
Compass Course
Compass Course is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Feasibility of a Purpose in Life Renewal Intervention for Adults With Persistent Symptoms After Concussion
NCT05780658
completednot_applicable
Compass Course: COVID-19
NCT05295238
completednot_applicable
Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups
NCT04767464
completednot_applicable
Compass Course: Efficacy Study
NCT03442686
Clinical Trials (4)
Showing 4 of 4 trials
NCT05780658Not Applicable
Feasibility of a Purpose in Life Renewal Intervention for Adults With Persistent Symptoms After Concussion
NCT05295238Not Applicable
Compass Course: COVID-19
NCT04767464Not Applicable
Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups
NCT03442686Not Applicable
Compass Course: Efficacy Study
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4